Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
H. Refsum, P.M. Ueland, O. Nygard, S.E. Vollset.
Homocysteine and cardiovascular disease.
Annu Rev Medicine, 49 (1998), pp. 31-62
[2.]
S.H. Mudd, H.L. Levy, F. Skovy.
Disorders of transsulfuration.
7.a ed, pp. 3111-3128
[3.]
I. Quere, H. Bellet, M. Hoffet, C. Janbon, P. Mares, J.C. Gris.
A woman with five consecutive fetal deaths. Case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages.
Fertil Steril, 69 (1998), pp. 152-154
[4.]
R.P.M. Steegers-Theunissen, G.H.J. Boers, J.F.M. Trijbels, T.K.A.B. Eskes.
Hyperhomocysteinemia and recurrent abortion or abruptio placentae.
Lancet, 239 (1992), pp. 1122-1123
[5.]
M.G.A.J. Wouters, G.H.J. Boers, H.J. Blom, F.J.M. Trijbels, C.M.G. Thomas, C.F. Borm, et al.
Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss.
Fertil Steril, 60 (1993), pp. 820-824
[6.]
R.P.M. Steegers-Theunissen, G.H.J. Boers, F.J.M. Trijbels, T.K.A.B. Eskes.
Maternal hyperhomocysteinemia: a risk factor for neural tube defects.
Metabolism, 43 (1994), pp. 1475-1480
[7.]
J.H. Walter, J.E. Wraith, F.J. White, C. Bridge, J. Till.
Strategies for the treatment of cystathionine-b-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years.
Eur J Pediatr, 157 (1998), pp. S71-S76
[8.]
R.W. Powers, R.W. Evans, A.K. Majors, J.I. Ojimba, R.B. Ness, W.R. Cromblenholme, et al.
Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation.
Am J Obstet Gynecol, 179 (1998), pp. 1605-1611
[9.]
M.R.C.O.G. Gerard Burke.
Intrauterine groth retardation, perinatal death, and maternal homocysteine levels.
N Engl J Med, 326 (1992), pp. 69-70
[10.]
M. Leeda, N. Riyazi, J.I.P. De Vries, C. Jakobs, N.P. Van Geijn, G.A. Dekker.
Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction.
Am J Obstet Gynecol, 179 (1998), pp. 135-139
[11.]
T.A.W. Goddijn-Wessel, M.G.A.J. Wouters, E.F. Van der Molen, M.D.E.H. Spuijbroek, R.P.M. Steegers-Theunissen, H.J. Blom, et al.
Hyperhomocysteinemia: a risk factor for placenta abruption or infarction.
Eur J Obstet Gynecol Reprod Biol, 66 (1996), pp. 23-29
[12.]
M.D. Heijer, T. Dossier, H.J. Blom, G.M.J. Bos, E. Briet, P.H. Reitsman, et al.
Hyperhomocysteinemia as a risk factor for deep vein thrombosis.
N Engl J Med, 34 (1996), pp. 759-762
Copyright © 2001. Sociedad Española de Ginecología y Obstetricia